Dianthus Therapeutics, Inc.
DNTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $132 | $15 | $132 |
| Short-Term Investments | $252 | $41 | $60 | $45 |
| Receivables | $1 | $0 | $6 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $1 | $0 | $4 |
| Total Curr. Assets | $281 | $177 | $82 | $181 |
| Property Plant & Equip (Net) | $2 | $1 | $1 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $82 | $0 | $0 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $10 | $1 | $0 | $0 |
| Total NC Assets | $93 | $2 | $1 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $374 | $179 | $83 | $190 |
| Liabilities | – | – | – | – |
| Payables | $5 | $3 | $1 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13 | $5 | $2 | $4 |
| Total Curr. Liab. | $18 | $10 | $8 | $11 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $2 | $1 | $1 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $6 |
| Total NC Liab. | $3 | $1 | $1 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $22 | $11 | $9 | $17 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $118 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$174 | -$89 | -$46 | -$326 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $352 | $169 | $74 | $173 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $374 | $179 | $83 | $190 |
| Net Debt | -$22 | -$132 | -$15 | -$132 |